Which hedge funds own BCAB? BIOATLA INC, Q2 2026 13F holders
0 tracked hedge funds disclosed a position in BCAB (BIOATLA INC) in their Q2 2026 13F filings, worth $0 in total. 5 exited: Stonepine Capital Management, LLC, ADAR1 Capital Management, LLC, Millennium Management LLC.
- 0
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 0
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 5
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $0
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $643k
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $0
- Combined value Sum of the holders' reported positions in the security.
- 0.0%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Stonepine Capital Management, LLC | 0.01% | $10.5k |
| ADAR1 Capital Management, LLC | 0.0% | $36.7k |
| Millennium Management LLC | 0.0% | $444k |
| Renaissance Technologies LLC | 0.0% | $82.2k |
| Citadel Advisors LLC | 0.0% | $70.1k |
Ownership over time
Who discovered BCAB first? Beta
| Silverarc Capital Management, LLC | Q4 2022 | 0.0 pts |
| Ikarian Capital, LLC | Q3 2021 | −0.3 pts |
| Great Point Partners LLC high conviction | Q3 2021 | −2.0 pts |
| Cormorant Asset Management, LP | Q4 2020 | −3.4 pts |
| Soleus Capital Management, L.P. high conviction | Q4 2020 | −6.1 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.